XML 17 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 28, 2024
Dec. 30, 2023
Current assets:    
Cash and cash equivalents $ 84,288 $ 43,942
Patient accounts receivable 265,193 236,558
Receivables under insured programs 12,465 9,250
Prepaid expenses 17,477 15,684
Other current assets 13,247 9,452
Total current assets 392,670 314,886
Property and equipment, net 17,373 20,548
Operating lease right of use assets 41,278 49,499
Goodwill 1,054,552 1,054,552
Intangible assets, net 89,566 94,010
Receivables under insured programs 22,425 21,315
Other long-term assets 45,530 58,175
Total assets 1,663,394 1,612,985
Current liabilities:    
Accounts payable and other accrued liabilities 36,435 30,130
Accrued payroll and employee benefits 87,672 67,160
Current portion of insurance reserves - insured programs 12,465 9,250
Current portion of insurance reserves 18,444 20,918
Securitization obligations 168,750 155,000
Current portion of long-term obligations 9,200 9,200
Current portion of operating lease liabilities 15,498 14,881
Other current liabilities 53,703 48,219
Total current liabilities 402,167 354,758
Long-term obligations, less current portion 1,271,656 1,276,341
Long-term insurance reserves - insured programs 22,425 21,315
Long-term insurance reserves 44,506 40,290
Operating lease liabilities, less current portion 31,718 39,818
Deferred income taxes 5,894 4,859
Other long-term liabilities 7,118 3,039
Total liabilities 1,785,484 1,740,420
Commitments and contingencies (Note 10)
Deferred restricted stock units 1,461 2,135
Stockholders' deficit:    
Preferred stock, $0.01 par value as of December 28, 2024 and December 30, 2023 5,000,000 shares authorized; none issued or outstanding
Common stock, $0.01 par value, 1,000,000,000 shares authorized; 193,225,177 and 190,733,153 issued and outstanding, respectively 1,932 1,907
Additional paid-in capital 1,256,680 1,239,757
Accumulated deficit (1,382,163) (1,371,234)
Total stockholders' deficit (123,551) (129,570)
Total liabilities, deferred restricted stock units, and stockholders' deficit $ 1,663,394 $ 1,612,985